Serge Belanger

Stock Analyst at Needham

(3.89)
# 618
Out of 4,893 analysts
361
Total ratings
48.39%
Success rate
10%
Average return

Stocks Rated by Serge Belanger

BioCryst Pharmaceuticals
Jun 27, 2025
Reiterates: Buy
Price Target: $17
Current: $8.88
Upside: +91.44%
CorMedix
Jun 24, 2025
Maintains: Buy
Price Target: $15$20
Current: $11.71
Upside: +70.79%
NewAmsterdam Pharma Company
Jun 12, 2025
Reiterates: Buy
Price Target: $40
Current: $22.02
Upside: +81.65%
Liquidia
Jun 2, 2025
Maintains: Buy
Price Target: $25$32
Current: $14.15
Upside: +126.15%
Arcutis Biotherapeutics
May 23, 2025
Reiterates: Buy
Price Target: $20
Current: $15.27
Upside: +30.98%
Viridian Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $36
Current: $17.12
Upside: +110.34%
Trevi Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $24
Current: $6.41
Upside: +274.41%
Omeros
May 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.46
Upside: -
Clearside Biomedical
May 15, 2025
Maintains: Buy
Price Target: $4$3
Current: $0.88
Upside: +242.66%
Verrica Pharmaceuticals
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.87
Upside: -
Reiterates: Buy
Price Target: $72
Current: $36.59
Upside: +96.78%
Reiterates: Buy
Price Target: $66
Current: $48.88
Upside: +35.02%
Maintains: Buy
Price Target: $60$55
Current: $32.98
Upside: +66.77%
Maintains: Buy
Price Target: $32$30
Current: $23.71
Upside: +26.53%
Reiterates: Buy
Price Target: $22
Current: $9.73
Upside: +126.10%
Maintains: Buy
Price Target: $5$4
Current: $1.24
Upside: +222.58%
Maintains: Buy
Price Target: $15$14
Current: $11.08
Upside: +26.35%
Reiterates: Buy
Price Target: $4
Current: $2.22
Upside: +80.18%
Reiterates: Hold
Price Target: n/a
Current: $22.21
Upside: -
Reiterates: Buy
Price Target: $46
Current: $33.03
Upside: +39.27%
Reiterates: Buy
Price Target: $28
Current: $15.51
Upside: +80.53%
Downgrades: Hold
Price Target: n/a
Current: $3.98
Upside: -